Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development, Feasibility, Efficacy, and Cost-effectiveness of an Online ACT Intervention for Disorders of Gut-Brain Interaction (Beta Trial)

NCT07175402 is registered in ClinicalTrials.gov with Örebro University, Sweden as lead sponsor.

NCT NCT07175402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07175402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development, Feasibility, Efficacy, and Cost-effectiveness of an Online ACT Intervention for Disorders of Gut-Brain Interaction (Beta Trial)
Lead sponsor
Örebro University, Sweden
Phase
Not applicable
Overall status
Completed
Start date
September 8, 2025
Completion date
December 31, 2025
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression/anxiety, dgbi